Tech Company Financing Transactions
Endovascular Engineering Funding Round
415 CAPITAL, S3 Ventures and Panakes Partners invested in a $42 million Series B funding round for Endovascular Engineering. The round was announced on 2/18/2025.
Transaction Overview
Company Name
Announced On
2/18/2025
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance its new clot removal technology platform for venous thromboembolism (VTE).
Company Information
Company Status
Private & Independent
Industry
Engineering
Mailing Address
3925 Bohannon Drive 300
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Email Address
Overview
Endovascular Engineering, Inc. ("E2"), is a mission-driven, venture-backed company focused on the development and deployment of next generation clot removal technologies that target venous thromboembolism.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Rose
Browse more venture capital transactions:
Prev: 2/18/2025: Pocket FM venture capital transaction
Next: 2/18/2025: Zebra Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs